AI assistant
InspireMD, Inc. — Director's Dealing 2021
Feb 10, 2021
34187_dirs_2021-02-10_709a1854-a1df-452e-942a-0d0668ed5ffd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2021-02-08
Reporting Person: BERMAN MICHAEL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-08 | Common Stock | P | 80640 | $0.62 | Acquired | 241275 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-08 | Warrants | $0.682 | P | 40320 | Acquired | 2026-02-08 | Common Stock (40320) | Direct |
| 2020-08-31 | Options to purchase common stock (right to buy) | $0.39 | A | 52678 | Acquired | 2030-08-31 | Common Stock (52678) | Direct |
Footnotes
F1: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 80,640 shares of common stock and warrants to purchase 40,320 shares of common stock together, as part of 80,640 units, at a purchase price of $0.62 per unit.
F2: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F3: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service.